What does CUSIP 09090D103 represent in this 13F holders report?

CUSIP 09090D103 is the security identifier for PHGE - BiomX Inc. - Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

How many institutions held PHGE - BiomX Inc. - Common Stock, $0.0001 par value per share in Q2 2024?

10 institutional investors reported PHGE - BiomX Inc. - Common Stock, $0.0001 par value per share for Q2 2024. Use the holders table for investor-level position and value details.

BiomX Inc. - Common Stock, $0.0001 par value per share (PHGE)

CUSIP: 09090D103

Q2 2024 13F Holders as of 30 Jun 2024

Security type / class: Equity / Common Stock, $0.0001 par value per share
Total 13F shares: 23,249,529
Total 13F value: $7,814,136
Share change: +9,478,690
SEC-reported price per share: $0.34
Number of holders: 10
Value change: +$3,181,319
Number of buys: 5
Number of sells: 3
Shares outstanding: 11,618,400

Security key

09090D103

Report period

Q2 2024

Institutions

Top holders

PHGE full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Tessera Defense & Homeland Security Inc. SEC filings Tessera Defense & Homeland Security Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 09090D103

Newer quarter: Q3 2025

Recent filing periods:

Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of PHGE - BiomX Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

OrbiMed Israel BioFund GP...

Disclosed value leader

OrbiMed Israel BioFund GP...

Comparable rows

0/15

Latest evidence

15 May 2024

3/4/5 13F Highest disclosed value: $5,250,517 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

OrbiMed Israel BioFund GP Limited Partnership has the largest disclosed position value at $5.25M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens OrbiMed Israel BioFund GP Limited Partnership's linked filing trail.

Disclosed position value Top 5

OrbiMed Israel BioFund GP Limited... $5.25M

Ugwumba Chidozie $1.02M

DEERFIELD MANAGEMENT COMPANY, L.P. $2.75M

ORBIMED ADVISORS LLC $2.03M

JOHNSON & JOHNSON $865.4K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
OrbiMed Israel BioFund GP Limited Partnership	3/4/5 10%+ Owner 3/4/5	— mixed-class rows	$5,250,517 13,777,980 shares mixed-class rows	—	15 May 2024
Ugwumba Chidozie	3/4/5 Exit Form 4 - former 10% owner 3/4/5	— denominator unverified	$1,018,989 2,997,025 shares	—	17 Oct 2022
DEERFIELD MANAGEMENT COMPANY, L.P.	13F Company 13F	— denominator unverified	$2,749,544 6,110,098 shares	—	31 Mar 2024
ORBIMED ADVISORS LLC	13F Company 13F	— denominator unverified	$2,032,915 4,517,589 shares	—	31 Mar 2024
JOHNSON & JOHNSON	13F Company 13F	— denominator unverified	$865,440 1,923,201 shares	—	31 Mar 2024
8VC GP I, LLC	13F Company 13F	— denominator unverified	$488,786 1,086,191 shares	—	31 Mar 2024

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

23,249,529

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q3 2025 Across Filers

Q3 2025 holders

Q2 2024 holders

Holder diff

Investor	Q3 2025 Shares	Q2 2024 Shares	Share Diff	Share Chg %	Q3 2025 value	Q2 2024 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend